Skip to Content

← See all Senna Plus brands

Senna Plus by NCS HealthCare of KY, Inc dba Vangard Labs

Dosage form: tablet
Ingredients: DOCUSATE SODIUM 50mg, SENNOSIDES 8.6mg
Labeler: NCS HealthCare of KY, Inc dba Vangard Labs
NDC Code: 0615-5533

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

Senna Plus

Active ingredient (in each tablet)

Sennosides from Senna Concentrate 8.6 mg

Sodium Dioctylsulfosuccinate 50 mg

Purpose

Laxetive

Stool Softener

Uses

• relieves occasional constipation (irregularity)

• generally produces a bowel movement in 6 - 12 hours

Warnings

Do not use

• laxative products for longer than 1 week unless directed by a doctor

• if you are now taking mineral oil, unless directed by a doctor

Ask a doctor before use if you have

• stomache pain, nausea, vomiting, noticed a sudden change in bowel habits that continues over a period of 2 weeks

Stop use and ask a doctor if

• you have rectal bleeding or fail to have a bowel movement after use of a laxative.

These may indicate a serious condition.

If pregnant or breast-feeding,

ask a health care professional before use. 

Keep out of reach of children.

In case of overdose, get medical help or contact a Poison Control Center right away. 

Directions

Take preferably at bedtime or as directed by a doctor            

agestarting dosagemaximum dosage
adults and children over 12 years2 tablets once a day4 tablets twice a day
children 6 to under 12 years1 tablet once a day2 tablets twice a day
children under 6 yearsask a doctor 

Other Information

Store at room temperature, USP

Other ingredients

Croscarmellose Sodium, Dicalcium Phosphate, FD&C Yellow #5 Lake**, FD&C Yellow #6 Lake, Hypromellose, Magnesium Silicate, Magnesium Stearate, Microcrystalline Cellulose, Mineral Oil, Polyethylene Glycol, Sodium Benzoate, Sodium Lauryl Sulfate, Starch, Stearic Acid, Titanium Dioxide and Triacetin.

Questions

Serious Adverse Effects Call: (800) 616-2471

**WARNING: Contains FD&C Yellow #5 Lake (Tartrazine) as a color additive.

*This product is not manufactured or distributed by Purdue Pharma L.P. owner of the registered trademark Senokto-S®.

Distributed by: Major Pharmaceuticals  31778 Enterprise Drive, Livonia, MI 48150, USA

Rev. 04/11 M-29

Principal Display Panel

Senna Plus Tablets

(Standardized senna concentrate equiv. to

8.6mg sennosides and sodium dioctylsulfosuccinate 50mg)

SENNA PLUS 
sennosides and docusate sodium tablet
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:0615-5533(NDC:0904-5512)
Route of AdministrationORALDEA Schedule    
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
DOCUSATE SODIUM (DOCUSATE) DOCUSATE SODIUM50 mg
SENNOSIDES (SENNOSIDES) SENNOSIDES8.6 mg
Inactive Ingredients
Ingredient NameStrength
CROSCARMELLOSE SODIUM 
CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS 
FD&C YELLOW NO. 5 
FD&C YELLOW NO. 6 
HYPROMELLOSES 
MAGNESIUM SILICATE 
MAGNESIUM STEARATE 
CELLULOSE, MICROCRYSTALLINE 
MINERAL OIL 
SODIUM BENZOATE 
SODIUM LAURYL SULFATE 
STARCH, TAPIOCA 
POLYETHYLENE GLYCOLS 
TITANIUM DIOXIDE 
STEARIC ACID 
TARTARIC ACID 
TRIACETIN 
Product Characteristics
ColorORANGEScoreno score
ShapeROUND (bi-convex) Size10mm
FlavorImprint CodeCPC;490
Contains    
Packaging
#Item CodePackage Description
1NDC:0615-5533-3131 TABLET (31 TABLET) in 1 BLISTER PACK
2NDC:0615-5533-3930 TABLET (30 TABLET) in 1 BLISTER PACK
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC MONOGRAPH NOT FINALpart33406/16/2011
Labeler - NCS HealthCare of KY, Inc dba Vangard Labs (050052943)
Establishment
NameAddressID/FEIOperations
NCS HealthCare of KY, Inc dba Vangard Labs050052943RELABEL(0615-5533), REPACK(0615-5533)

 
NCS HealthCare of KY, Inc dba Vangard Labs

← See all Senna Plus brands

Medically reviewed on Feb 27, 2018

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide